WFG
GILD icon

Wills Financial Group’s Gilead Sciences GILD Stock Holding History

Wills Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,200
Closed -$202K – 75
2016
Q1 		$202K Hold
2,200
– – 0.17% 71
2015
Q4 		$222K Hold
2,200
– – 0.2% 71
2015
Q3 		$216K Buy
2,200
+300
+16% +$33.3K 0.2% 68
2015
Q2 		$222K Buy
+1,900
New +$208K 0.19% 68

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wills Financial Group's GILD Position: Q2 2016 in Review

Wills Financial Group sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 2,200 shares — an estimated $202K sold.

Wills Financial Group first reported a position in GILD in Q2 2015 and held it in 4 quarters. The position peaked at $222K in Q4 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Wills Financial Group reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Wills Financial Group sold 2,200 Gilead Sciences shares in Q2 2016, an estimated $202K.
  • Wills Financial Group first reported a position in Gilead Sciences in Q2 2015 and held it in 4 quarters.
  • Wills Financial Group's Gilead Sciences position peaked at $222K in Q4 2015.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Wills Financial Group's 13F filing for Q2 2016, filed 4 Aug 2016.